We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Late Investigations, Reports Result in Form 483 for Hospira
Late Investigations, Reports Result in Form 483 for Hospira
November 4, 2013
FDA investigators rapped injectable giant Hospira for an inadequate response to findings of glass particles in drugs, resulting in a Form 483 for the drugmaker.